entertainment -WSS

entertainment

author：leisure time 2025-08-26 01:32:27 - browse：9255

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： #NeedHerScience: shining a light on gender disparities in medicine

WSS

Colonoscopy at 40? Study finds a possible benefit

The FDA must approve intranasal treatments for anaphylaxis

Federal weight loss drug coverage is 30 years out of date

Videos point to link between seizures and unexplained toddler deaths

Gene therapy has helped boys walk. Can scientists keep it that way?

New guidelines on severe brain injury complicate already difficult decisions

entertainment

entertainment

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

New guidelines on severe brain injury complicate already difficult decisions

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

With FDA staff opposed to Sarepta therapy, top official intervened

Duchenne breakthrough therapy leaves behind pioneering families

JPM: CVS says Medicare Advantage patients are impacting profits

Trump demands the U.S. pay no more for drugs than other countries … again

STAT's guide to the next generation of CAR

Walensky prepares to leave CDC — and Congress — behind

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Wikipedia

#NeedHerScience: shining a light on gender disparities in medicine

CDC concerned about possible undetected monkeypox spread in U.K.

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Why are elite athletes different? Take a look at their microbes

Cloning humans is technically possible. It's curious no one has tried

Donald Trump's relentless attacks on special counsel Jack Smith

entertainment

focus

hotspot

explore